Literature DB >> 4179565

Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.

S L Rivers, M E Patno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4179565

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Cyclophosphamide in the treatment of multiple myeloma.

Authors:  S J Salokannel; I P Palva; T Timonen; W J Kaipainen
Journal:  Blut       Date:  1971-09

2.  Factors influencing the prognosis in myelomatosis.

Authors:  A A Dawson; D Ogston
Journal:  Postgrad Med J       Date:  1971-10       Impact factor: 2.401

3.  Combination therapy for myelomatosis.

Authors:  L Azam; I W Delamore
Journal:  Br Med J       Date:  1974-12-07

4.  The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.

Authors:  Daniel M Green; Vikki G Nolan; Pamela J Goodman; John A Whitton; DeoKumar Srivastava; Wendy M Leisenring; Joseph P Neglia; Charles A Sklar; Sue C Kaste; Melissa M Hudson; Lisa R Diller; Marilyn Stovall; Sarah S Donaldson; Leslie L Robison
Journal:  Pediatr Blood Cancer       Date:  2013-08-12       Impact factor: 3.167

5.  Is there a role for 'modified VAD' in the treatment of multiple myeloma?

Authors:  A Agazzi; S Sammassimo; D Laszlo; Sj Liptrott; R Cascio; A Alietti; C Rabascio; P Mancuso; G Pruneri; G Martinelli
Journal:  Ecancermedicalscience       Date:  2009-06-04

Review 6.  The treatment of multiple myeloma--an important MRC trial.

Authors:  P W Johnson; P J Selby
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

7.  Multi-drug combination therapy with vincristine-melphalan-cyclophosphamide-prednisolone was more effective than cyclophosphamide-prednisolone in stage III myeloma. The Nagoya Myeloma Cooperative Study Group.

Authors:  K Shimizu; O Kamiya; N Hamajima; H Mizuno; M Kobayashi; N Hirabayashi; H Takeyama; R Kato; K Kawashima; M Nitta
Journal:  Jpn J Cancer Res       Date:  1990-12

8.  Multiple myeloma in Korea--clinical analysis and treatment results in 61 cases.

Authors:  H J Kim; D S Heo; Y J Bang; S J Lee; D H Choi; S Y Park; B K Kim; N K Kim; M Heo; M Lee
Journal:  Korean J Intern Med       Date:  1987-01       Impact factor: 2.884
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.